X T L Biopharmaceuticals reported $-255000 in Net Income for its fiscal quarter ending in December of 2024.


Net Income Change Date
Alaunos Therapeutics USD -742000 385K Dec/2024
Bioline Rx USD -3940000 9.07M Jun/2025
Teva Pharmaceutical Industries USD 282M 68M Jun/2025
X T L Biopharmaceuticals USD -255000 298K Dec/2024